Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

170.16
-2.8300-1.64%
Pre-market: 172.001.84+1.08%05:35 EDT
Volume:7.36M
Turnover:1.26B
Market Cap:301.01B
PE:71.20
High:174.17
Open:173.47
Low:168.54
Close:172.99
Loading ...

Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More

Zacks
·
11 Apr

Citigroup Adjusts Price Target on AbbVie to $210 From $215, Keeps Buy Rating

MT Newswires Live
·
11 Apr

Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip?

Zacks
·
10 Apr

Pharma Shares Reverse Losses After Tariff Pause

Dow Jones
·
10 Apr

Why drug stocks are no longer a safe haven from the stock market's turmoil

Dow Jones
·
09 Apr

Pharma Stocks Slide Further After Trump Reiterates Tariff Threats on Drugs -- Update

Dow Jones
·
09 Apr

Morgan Stanley Adjusts Price Target on AbbVie to $241 From $239, Keeps Overweight Rating

MT Newswires Live
·
09 Apr

Shares of Drugmakers Down After Trump Threatens Tariffs on Sector

THOMSON REUTERS
·
09 Apr

AbbVie price target raised to $241 from $239 at Morgan Stanley

TIPRANKS
·
09 Apr

US STOCKS-Futures tumble as China hits back with more barriers on US goods

Reuters
·
09 Apr

BUZZ-US drugmakers fall as Trump threatens tariffs again

Reuters
·
09 Apr

Gilead Sciences Down 3%, Amgen Down 2.9%, Pfizer Down 2.7%

THOMSON REUTERS
·
09 Apr

Drugmakers Down Premarket After Trump Threatens Tariffs on Sector

THOMSON REUTERS
·
09 Apr

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

Dow Jones
·
09 Apr

AbbVie Hold Rating: Balancing Strong Immunology Growth with Challenges in Aesthetics, Neuroscience, and Oncology

TIPRANKS
·
09 Apr

AbbVie Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
09 Apr

Biopharma Shakeup: Goldman Boosts J&J, Eli Lilly While Flagging Risks at Pfizer and AbbVie

GuruFocus
·
09 Apr

AbbVie Coverage Assumed by Goldman Sachs at Neutral

Dow Jones
·
09 Apr

AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell Arteritis

Zacks
·
08 Apr

Goldman turns cautious on major pharma names, sees select upside at Eli Lilly

Investing.com
·
08 Apr